| Wed, Dec 9, 2009 | | • | Sangamo says early data from ALS study is positive
AP (Wed, Dec 9)
| | • | Sangamo drug helps muscle in 1/3 of ALS patients
at Reuters (Wed, Dec 9)
| | • | Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
PR Newswire (Wed, Dec 9)
| | Wed, Nov 18, 2009 | | • | Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
PR Newswire (Wed, Nov 18)
| | Fri, Nov 6, 2009 | | • | SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Sangamo 3Q loss narrows on payments, lower costs
AP (Thu, Nov 5)
| | • | New Star Analyst Rankings for Sangamo BioSciences, Inc.
StarMine (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Sangamo Biosciences, Inc. Q3 2009 Earnings Call Transcript
at Seeking Alpha (Wed, Nov 4)
| | • | SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
EDGAR Online (Wed, Nov 4)
| | • | Sangamo BioSciences Reports Third Quarter 2009 Financial Results
PR Newswire (Wed, Nov 4)
| | • | Q3 2009 Sangamo BioSciences Earnings Release - After Market Close
CCBN (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | Sangamo BioSciences Announces Presentation at Merriman Curhan Ford's Investor Summit 2009
PR Newswire (Tue, Nov 3)
| | Fri, Oct 30, 2009 | | • | 4-Star Stocks on the Upswing
at Motley Fool (Fri, Oct 30)
| | Wed, Oct 28, 2009 | | • | Sangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast
PR Newswire (Wed, Oct 28)
| | • | Sangamo BioSciences Research Collaborators Awarded Grant From California Institute for Regenerative Medicine to Develop Zinc Finger Nuclease-Based Stem Cell Therapy for HIV/AIDS
PR Newswire (Wed, Oct 28)
| | Fri, Oct 23, 2009 | | • | Sigma-Aldrich profit up, sales drop slightly
at bizjournals.com (Fri, Oct 23)
| | Thu, Oct 22, 2009 | | • | Sigma-Aldrich profit up, sales drop slightly
at bizjournals.com (Thu, Oct 22)
| | Tue, Oct 20, 2009 | | • | Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting
PR Newswire (Tue, Oct 20)
| | Mon, Oct 19, 2009 | | • | Coverage initiated on Sangamo BioSci by Brean Murray
Briefing.com (Mon, Oct 19)
| | Fri, Oct 16, 2009 | | • | StockPreacher.com Issues Trading Outlook for GenVec Inc.
GlobeNewswire (Fri, Oct 16)
|
Add SGMO News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
Headlines
